Leukotriene B4 receptors as therapeutic targets for ophthalmic diseases

Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
Toshiaki HirakataTakehiko Yokomizo

Abstract

Leukotriene B4 (LTB4) is an inflammatory lipid mediator produced from arachidonic acid by multiple reactions catalyzed by two enzymes 5-lipoxygenase (5-LOX) and LTA4 hydrolase (LTA4H). The two receptors for LTB4 have been identified: a high-affinity receptor, BLT1, and a low-affinity receptor, BLT2. Our group identified 12(S)-hydroxy-5Z,8E,10E-heptadecatrienoic acid (12-HHT) as a high-affinity BLT2 ligand. Numerous studies have revealed critical roles for LTB4 and its receptors in various systemic diseases. Recently, we also reported the roles of LTB4, BLT1 and BLT2 in the murine ophthalmic disease models of mice including cornea wound, allergic conjunctivitis, and age-related macular degeneration. Moreover, other groups revealed the evidence of the ocular function of LTB4. In the present review, we introduce the roles of LTB4 and its receptors both in ophthalmic diseases and systemic inflammatory diseases. LTB4 and its receptors are putative novel therapeutic targets for systemic and ophthalmic diseases.

References

Jan 1, 1988·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·C P HerbortM Mochizuki
May 1, 1986·Archives of Ophthalmology·J A ParkerM H Friedlaender
Sep 1, 1984·British Journal of Pharmacology·S D BrainA K Black
Jul 17, 1981·European Journal of Pharmacology·P BhattacherjeeK E Eakins
Jul 1, 1995·European Journal of Biochemistry·J A Mancini, J F Evans
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·R J GriffithsA J Milici
Jan 15, 1996·The Journal of Clinical Investigation·C R TurnerH J Showell
Jan 20, 1999·Immunology and Cell Biology·J R SmithK A Williams
Sep 28, 2000·The Journal of Biological Chemistry·S WangT Laz
Mar 30, 2001·The Journal of Biological Chemistry·T YokomizoT Shimizu
May 19, 2001·Life Sciences·T YokomizoT Shimizu
Oct 6, 2001·Survey of Ophthalmology·M Rolando, M Zierhut
Mar 15, 2002·Current Allergy and Asthma Reports·A Keane-Myers
May 27, 2003·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Masafumi ZaitsuEiichi Ishii
Aug 5, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Andrew M Tager, Andrew D Luster
Sep 2, 2003·Nature Immunology·Andrew M TagerAndrew D Luster
Sep 2, 2003·Nature Immunology·Vanessa L OttBradley J Swanson
Sep 2, 2003·Nature Immunology·Katayoon GoodarziUlrich H von Andrian
Dec 6, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Krishnaprasad SubbaraoBodduluri Haribabu
Jul 21, 2004·Trends in Cardiovascular Medicine·Ryuji OhashiChangyi Chen
Oct 14, 2004·The Journal of Allergy and Clinical Immunology·Chiara MondinoPaolo Montuschi
Jan 8, 2005·The Journal of Allergy and Clinical Immunology·Santa Jeremy Ono, Mark B Abelson
Jun 28, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Karsten Gronert
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kan TerawakiTakao Shimizu
Nov 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Magnus BäckGöran K Hansson
Mar 28, 2006·Investigative Ophthalmology & Visual Science·Tianjiang LiaoHui Shao
Mar 29, 2006·The Journal of Experimental Medicine·Nancy D KimAndrew D Luster
May 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hong QiuJesper Z Haeggström
Jul 12, 2007·The Biochemical Journal·Robert C Murphy, Miguel A Gijón
Jul 31, 2007·Lancet·Christopher Em Griffiths, Jonathan Nwn Barker
Apr 2, 2008·The Journal of Experimental Medicine·Toshiaki OkunoTakao Shimizu
Apr 17, 2008·Molecular Pharmacology·Rodrigo MedeirosJoão Batista Calixto
Mar 17, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Geun-Young KimJae-Hong Kim
Oct 3, 2009·Journal of Lipid Research·Christine A CurcioMartin Rudolf
Dec 8, 2009·Journal of Lipid Research·Sachidananda Kenchegowda, Haydee E P Bazan
Mar 11, 2010·Prostaglandins & Other Lipid Mediators·Alexandra HicksLouis M Renzetti
Jul 27, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Steven P MathisBodduluri Haribabu
Sep 4, 2010·Science·Robert J SnelgroveJ Edwin Blalock
Sep 30, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Na LiHaydee E P Bazan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Prostaglandins, Leukotrienes, and Essential Fatty Acids
Andrew M Tager, Andrew D Luster
Archives of Biochemistry and Biophysics
Takehiko YokomizoT Shimizu
Seminars in Immunology
Kazuko Saeki, Takehiko Yokomizo
© 2022 Meta ULC. All rights reserved